Naba Al Saha Medical Services Company (TADAWUL:9546)

Saudi Arabia · Delayed Price · Currency is SAR

43.40

-0.74 (-1.68%)

Mar 3, 2026, 2:58 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Pharmaceuticals	12.69M	11.97M	10.82M	9.12M	-
Pharmaceuticals Growth	6.02%	10.58%	18.59%	-	-
Medical Services	181.60M	170.39M	118.86M	108.56M	-
Medical Services Growth	6.58%	43.35%	9.49%	-	-
Medical Services and Pharmaceutical Products	-	-	-	-	115.68M
Total	194.28M	182.35M	129.68M	117.68M	115.68M
Total Growth	6.54%	40.61%	10.20%	1.73%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Saudi Arabia	194.28M	182.35M	129.68M	117.68M	115.68M
Saudi Arabia Growth	6.54%	40.61%	10.20%	1.73%	-
Total	194.28M	182.35M	129.68M	117.68M	115.68M
Total Growth	6.54%	40.61%	10.20%	1.73%	-

Source: S&P Global Market Intelligence.